Company / Inventory
Ultragenyx Pharmaceutical Inc. Inventory History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$52.0M
FY2025
5-year range
$16.2M / $52.0M
FY2021-FY2025
Trend
+15.6%
vs FY2024
Sector context
#55 of 105
Health Care
What the data says
At $52M, Ultragenyx Pharmaceutical Inc.'s inventory ranks #55 of 105 in the Health Care sector. Inventory has increased for 8 consecutive years, from $757,000 in FY2017 to $52M in FY2025.
Based on SEC 10-K filings.
$52M in FY2025 with a 5-year CAGR of +31.9%.
Improved from $34M to $52M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +24.8%
- 5-Year CAGR
- +31.9%
- 10-Year CAGR
- -
Sector benchmark
#55 of 105 in Health CareTop 52% of 105This company $52.0M Sector average $885.3M
▼
-94.1% below sector average
Key checks
Key Insights
- Ultragenyx Pharmaceutical Inc.'s inventory has grown for 8 consecutive years.
- 5-year CAGR of +31.9%, indicating consistent growth.
- In FY2025, inventory increased 15.6% year-over-year.
- Ranks #55 out of 105 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -2.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $52.0M | +15.6% |
| FY2024 | $45.0M | +32.5% |
| FY2023 | $34.0M | +26.9% |
| FY2022 | $26.8M | +64.9% |
| FY2021 | $16.2M | +24.4% |
| FY2020 | $13.0M | +13.0% |
| FY2019 | $11.5M | +63.4% |
| FY2018 | $7.1M | +833.3% |
| FY2017 | $757.0K | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026